Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality
Abstract Aims Heart failure (HF) with preserved ejection fraction (HFpEF) is associated with cardiovascular (CV) and non‐CV events, but long‐term risk is poorly studied. We assessed incidence and predictors of the long‐term CV and non‐CV events. Methods and results Patients presenting with acute HF,...
Main Authors: | Angiza Shahim, Marion Hourqueig, Lars H. Lund, Gianluigi Savarese, Emmanuel Oger, Ashwin Venkateshvaran, Lina Benson, Jean‐Claude Daubert, Cecilia Linde, Erwan Donal, Camilla Hage |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14302 |
Similar Items
-
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
by: Lars H. Lund, et al.
Published: (2022-02-01) -
Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
by: Davide Stolfo, et al.
Published: (2022-11-01) -
Do we need a definition of acute heart failure with preserved ejection fraction?
by: Agnieszka Kapłon-Cieślicka, et al.
Published: (2021-01-01) -
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
by: Giuseppe Vergaro, et al.
Published: (2019-10-01) -
The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction
by: Gregory A. Nichols, et al.
Published: (2023-08-01)